Publications
(2011)
Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab. Proc Natl Acad Sci U S A. 114, E4223-E4232
(2017) NECAT
9700 S. Cass Ave.
Bldg. 436E
Argonne, IL 60439
630.252.0689
csalbego@cornell.edu
Copyright © 2024, NECAT
Design by FreeBiezz